Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
60 seconds · no obligationView Profile
Rectal cancer originates in the tissues of the rectum, forming malignant tumours that affect lower bowel function. Common symptoms prompting consultation with a doctor include changes in bowel habits, rectal bleeding, persistent abdominal discomfort, or unexplained fatigue. Establishing an appropriate multidisciplinary course of care depends on an individual specialist assessment, diagnostic endoscopy, and radiological staging. Compare hospitals in Turkey that treat Rectal Cancer and get a free review of your medical records.

1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
OncologyVerified
English · Turkish
60 seconds · no obligationView Profile
Rectal cancer originates in the tissues of the rectum, forming malignant tumours that affect lower bowel function. Common symptoms prompting consultation with a doctor include changes in bowel habits, rectal bleeding, persistent abdominal discomfort, or unexplained fatigue. Establishing an appropriate multidisciplinary course of care depends on an individual specialist assessment, diagnostic endoscopy, and radiological staging.
Specialty: Oncology
Depending on the stage and your medical history, doctors may recommend:
The cost of treating Rectal Cancer depends on the diagnosis and the treatment chosen. Doctors first review your medical records — free of charge — and you then receive an itemised quote.
Options may include Radiation Therapy for Colorectal Cancer, Complex Diagnosis of Colorectal Cancer. Your doctor chooses the approach after reviewing your tests and scans.
Rectal Cancer is treated by Oncology specialists. 2 clinics in Turkey on our platform offer this treatment.
Rectal cancer develops when malignant cells form in the tissues of the rectum, which forms the final section of the large intestine before the anal canal. Although closely related to colon cancer, tumors in the rectum present unique surgical and radiotherapeutic challenges due to the narrow structure of the pelvic cavity and proximity to vital pelvic organs and nerves. Early detection significantly alters the management pathway and long-term outcomes for patients.
International patients seeking initial investigation or targeted therapy for rectal cancer often present with one or several progressive symptoms. Recognizing these early indicators is crucial for prompt diagnosis:
Establishing an accurate anatomical location, histological grade, and clinical stage of a rectal tumor is mandatory before initiating any treatment plan. Specialists in oncology and gastroenterology rely on precise diagnostic tools to evaluate the depth of wall invasion and regional lymph node involvement.
When preparing to visit a clinic in Turkey for an evaluation, prospective patients should compile all recent medical records. Hospitals will require high-resolution pelvic Magnetic Resonance Imaging (MRI) discs, Endorectal Ultrasonography (ERUS) reports, contrast-enhanced Computed Tomography (CT) scans of the chest and abdomen, baseline Carcinoembryonic Antigen (CEA) blood markers, and biopsy tissue blocks or glass slides if a diagnosis has already been made locally.
Upon arrival, the diagnostic pathway typically includes:
Management of rectal tumors requires a multidisciplinary tumor board decision involving medical oncologists, radiation oncologists, radiodiagnosticians, and surgeons trained in general surgery or colorectal procedures. Depending on the tumor location in the upper, middle, or lower third of the rectum, treatment protocols vary.
| Option | Typically used when | Things to know |
|---|---|---|
| Neoadjuvant Chemoradiotherapy | Locally advanced tumors (T3/T4 or node-positive) prior to surgical resection. | Combines targeted radiation with systemic chemotherapy to shrink the primary tumor and decrease local recurrence rates. |
| Total Mesorectal Excision (TME) | Standard surgical approach for resectable rectal tumors in the mid or lower rectum. | Involves removing the rectum along with an intact envelope of surrounding fatty mesorectal tissue and lymph nodes. |
| Sphincter-Sparing Surgery | Tumors located sufficiently far from the anal sphincter complex. | Allows primary anastomosis, avoiding a permanent stoma; temporary diverting stomas may still be created to allow healing. |
| Abdominoperineal Resection (APR) | Low rectal cancers invading the anal sphincter muscle complex. | Requires complete removal of the rectum, anus, and sphincter, resulting in a permanent end colostomy. |
| Adjuvant Systemic Chemotherapy | Post-surgery for patients with identified node involvement or high-risk features. | Designed to eliminate residual microscopic disease and reduce the risk of systemic metastasis. |
Traveling abroad for complex oncological care requires structured planning and realistic expectations. The treatment timeline begins with a remote document review, where multidisciplinary specialists evaluate submitted imaging and pathology files to determine preliminary suitability for travel.
Patients undergoing major pelvic surgery like TME usually spend between 7 to 10 days admitted to the hospital, followed by an additional 10 to 14 days in local accommodation for postoperative monitoring, drain management, and stoma education if applicable. If neoadjuvant chemoradiation is recommended prior to surgery, extended stays of 5 to 6 weeks or planned dual trips may be necessary. Before returning home, international patients receive fully translated medical records, pathology reports, operative summaries, and clear directions for routine surveillance, such as periodic CEA monitoring, colonoscopies, and follow-up imaging arranged with their home medical team.
International travel is not advisable for individuals experiencing severe mechanical bowel obstruction, unmanaged systemic infection, severe symptomatic anaemia, or uncontrolled pelvic pain. Flying immediately after major open or laparoscopic abdominal surgery carries significant risks, including deep vein thrombosis, pulmonary embolism, and surgical wound breakdown.
Patients must seek immediate local emergency care if they experience any of the following warning signs:
Total Mesorectal Excision is the gold-standard surgical technique for rectal cancer. It involves removing the affected section of the rectum along with the mesorectum, an intact fatty tissue envelope containing blood vessels and lymph nodes. This precise dissection minimizes the risk of local cancer recurrence while preserving surrounding nerves.
Whether a stoma is permanent depends on the tumor's location relative to the anal sphincter muscles. Lower tumors involving the sphincter require complete excision (Abdominoperineal Resection), leading to a permanent colostomy. Higher tumors allow sphincter-preserving surgery, though a temporary stoma may be created to protect the healing intestinal join.
Initial hospitalization after rectal surgery generally lasts 7 to 10 days. Patients are advised to remain in Turkey for an additional 1 to 2 weeks for monitoring, suture or drain removal, stoma care training, and final clearance from the surgical team before flying home.
Yes. Neoadjuvant chemoradiation is frequently used to shrink locally advanced rectal tumors before surgery. If prescribed, treatment typically spans 5 to 6 weeks. Patients can choose to stay in Turkey for the full duration or return home during the recovery window before surgical excision.
Prior to discharge, your treating team provides detailed operative notes, pathology results, and treatment summaries translated into English. You will present these documents to your local oncologist or GP to coordinate long-term surveillance, including regular blood tests, imaging scans, and routine colonoscopies.
Your request is in!
Your coordinator will contact you — usually within 2 hours, 24/7.
Want a faster, more accurate assessment?
Add photos & medical detailsLeave your number — a coordinator calls you in your language, usually within 15 minutes during office hours.
Thank you!
A coordinator will contact you at the time you chose.